GPR120 Agonist 2 is primarily used in research focused on metabolic disorders and inflammation. It activates the GPR120 receptor, which plays a significant role in regulating glucose metabolism and insulin sensitivity. This makes it a potential candidate for developing treatments for type 2 diabetes and obesity. Additionally, its anti-inflammatory properties are being explored for managing chronic inflammatory conditions such as arthritis and inflammatory bowel disease. Researchers also investigate its potential in improving fatty acid metabolism and reducing lipid accumulation, which could benefit cardiovascular health. Its application in preclinical studies helps in understanding the receptor's role in metabolic and inflammatory pathways.